Investors
Helix BioMedix, Inc (OTCBB: HXBM), is committed to building long term shareholder value through strategic management of our diverse peptide library.
The company’s stock symbol is HXBM.OB. For a complete listing of reports and filings please visit the Securities and Exchange Commission at www.sec.gov…click to learn more
Management Team…click to learn more.
Board of Directors…click to learn more.
SEC reports and filings. For a complete listing of reports and filings please visit the Securities and Exchange Commission at www.sec.gov
The Management and Board of Directors of Helix BioMedix Inc. are committed to operating the company in an efficient, compliant and ethical manner, thereby improving our ability for growth and creation of value for our stockholders…click to learn more.
Helix BioMedix, Inc. is pleased to offer the following online services…click to learn more.

Online Access to Annual Report and Proxy Statement
Electronic Proxy Voting
Beneficial Stockholders
Registered Stockolders

Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”.

In this section you’ll find Helix’s Stock Quote, SEC Reports, and information about our Corporate Governance practices.

Corporate Profile
Click here to view [pdf]

2011 Annual Shareholders MeetingListen to Webcast
May 25, 2011 , 8:00 a.m. Pacific Time
Hilton Garden Inn
22600 Bothell Everett Hwy, Bothell, WA  98021

TRANSFER AGENT
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC
Standard US postal mail address: 59 Maiden Lane, Plaza Level, New York, NY 10038
Overnight/express delivery: 6201 15th Avenue, Brooklyn, NY 112191
Toll free: 800-937-5449 • Phone: 718-921-8124

INVESTOR RELATIONS CONTACT
Matt Kreps
Shelton Group
972-239-5119 x125
mkreps@sheltongroup.com